Publications
2020-Current
2025
Bimodal Genomic Approach Predicting Semaphorin 7A (SEMA7A) as Prognostic Biomarker in Adrenocortical Carcinoma
2025 June 21
Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma
2025 June 4
2024
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples
2024 August 20
Metabolism-focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
2024 January 24
2023
Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein Targets
2023 August 22
2022
Integrative epigenomic analyses of small cell lung
cancer cells demonstrates the clinical translational
relevance of gene body methylation
2022 November 18
2021
CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics
2021 January 08
Nucleic Acids Research, Volume 49, Issue D1, 8 January 2021, Pages D1083-D1093
R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin
2021 May 28
2020
Epigenome-wide DNA methylation analysis of small cell lung cancer cell lines suggests potential chemotherapy targets
2020 June 25
Candidate biomarker assessment for pharmacological response
2020 July 8
Epigenetic Regulation of DNA Repair Pathway Choice by MacroH2A1 Splice Variants Ensures Genome Stability
2020 September 3
SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures
2020 October 20